[Coronary permeability and left ventricular function following thrombolytic therapy]. 1991

J Suárez de Lezo, and A Medina, and M Pan, and E Hernández, and M Sancho, and A Bethencourt, and M Romero, and F Melián, and J Segura, and F Jiménez
Hospital Nuestra Señora del Pino, Las Palmas.

We study 40 patients, 55 +/- 7 years old with acute myocardial infarction treated early by thrombolytic therapy (20 STK and 20 rt-PA). All patients were angiographically studied in the following conditions: 1) baseline, before initiating therapy. 2) Three hours after treatment. 3) Twenty four hours later. 4) Before discharge. The infarct related artery was patent 24 hours after treatment in 31 patients (78%); five of them were patent before treatment, and we observed an early reperfusion in 20 patients (57%) and late reperfusion in 6 patients (17%). The number of patients with angiographic evidence of intraluminal thrombus decreased progressively through conditions while the grade TIMI of coronary perfusion increased in the absence of reocclusion. Final regional wall motion of infarct related myocardial zones and their degree of recovery were significantly higher in recanalized patients, as compared with non-reperfused patients. Similarly, left ventricular functional recovery was higher in patients with antegrade of collateral flow to the infarct area, as compared with totally occluded patients.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D005343 Fibrinolytic Agents Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. Antithrombic Drug,Antithrombotic Agent,Antithrombotic Agents,Fibrinolytic Agent,Fibrinolytic Drug,Thrombolytic Agent,Thrombolytic Agents,Thrombolytic Drug,Antithrombic Drugs,Fibrinolytic Drugs,Thrombolytic Drugs,Agent, Antithrombotic,Agent, Fibrinolytic,Agent, Thrombolytic,Agents, Antithrombotic,Drug, Antithrombic,Drug, Fibrinolytic,Drug, Thrombolytic,Drugs, Antithrombic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014654 Vascular Patency The degree to which BLOOD VESSELS are not blocked or obstructed. Patency, Vascular,Patencies, Vascular,Vascular Patencies
D015425 Myocardial Reperfusion Generally, restoration of blood supply to heart tissue which is ischemic due to decrease in normal blood supply. The decrease may result from any source including atherosclerotic obstruction, narrowing of the artery, or surgical clamping. Reperfusion can be induced to treat ischemia. Methods include chemical dissolution of an occluding thrombus, administration of vasodilator drugs, angioplasty, catheterization, and artery bypass graft surgery. However, it is thought that reperfusion can itself further damage the ischemic tissue, causing MYOCARDIAL REPERFUSION INJURY. Coronary Reperfusion,Reperfusion, Myocardial,Coronary Reperfusions,Myocardial Reperfusions,Reperfusion, Coronary,Reperfusions, Coronary,Reperfusions, Myocardial
D016276 Ventricular Function The hemodynamic and electrophysiological action of the HEART VENTRICLES. Function, Ventricular,Functions, Ventricular,Ventricular Functions
D017023 Coronary Angiography Radiography of the vascular system of the heart muscle after injection of a contrast medium. Angiography, Coronary,Angiographies, Coronary,Coronary Angiographies

Related Publications

J Suárez de Lezo, and A Medina, and M Pan, and E Hernández, and M Sancho, and A Bethencourt, and M Romero, and F Melián, and J Segura, and F Jiménez
March 1995, Clinical and experimental pharmacology & physiology,
J Suárez de Lezo, and A Medina, and M Pan, and E Hernández, and M Sancho, and A Bethencourt, and M Romero, and F Melián, and J Segura, and F Jiménez
August 1991, American heart journal,
J Suárez de Lezo, and A Medina, and M Pan, and E Hernández, and M Sancho, and A Bethencourt, and M Romero, and F Melián, and J Segura, and F Jiménez
July 1978, Circulation,
J Suárez de Lezo, and A Medina, and M Pan, and E Hernández, and M Sancho, and A Bethencourt, and M Romero, and F Melián, and J Segura, and F Jiménez
August 1990, European heart journal,
J Suárez de Lezo, and A Medina, and M Pan, and E Hernández, and M Sancho, and A Bethencourt, and M Romero, and F Melián, and J Segura, and F Jiménez
February 1990, Angiology,
J Suárez de Lezo, and A Medina, and M Pan, and E Hernández, and M Sancho, and A Bethencourt, and M Romero, and F Melián, and J Segura, and F Jiménez
May 1985, Vnitrni lekarstvi,
J Suárez de Lezo, and A Medina, and M Pan, and E Hernández, and M Sancho, and A Bethencourt, and M Romero, and F Melián, and J Segura, and F Jiménez
February 1991, Klinicheskaia meditsina,
J Suárez de Lezo, and A Medina, and M Pan, and E Hernández, and M Sancho, and A Bethencourt, and M Romero, and F Melián, and J Segura, and F Jiménez
December 1991, The American journal of cardiology,
J Suárez de Lezo, and A Medina, and M Pan, and E Hernández, and M Sancho, and A Bethencourt, and M Romero, and F Melián, and J Segura, and F Jiménez
March 2004, Kardiologia polska,
J Suárez de Lezo, and A Medina, and M Pan, and E Hernández, and M Sancho, and A Bethencourt, and M Romero, and F Melián, and J Segura, and F Jiménez
April 1987, Journal of the American College of Cardiology,
Copied contents to your clipboard!